Insights into novel emerging epigenetic drugs in myeloid malignancies

by Namrata S. Chandhok, Thomas Prebet
Published 2019-08-01

Emerging treatment options for patients with high-risk myelodysplastic syndrome

by Jan Philipp Bewersdorf, Hetty Carraway, Thomas Prebet
Published 2020-11-01

Definition of Personalized Medicine and Targeted Therapies: Does Medical Familiarity Matter?

by Valentyn Fournier, Thomas Prebet, Alexandra Dormal, Maïté Brunel, Robin Cremer, Loris Schiaratura
Published 2021-01-01

Epigenetics in Cancer: A Hematological Perspective.

by Maximilian Stahl, Nathan Kohrman, Steven D Gore, Tae Kon Kim, Amer M Zeidan, Thomas Prebet
Published 2016-10-01

Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases

by Philippa Li, Giulia Biancon, Timil Patel, Zenggang Pan, Shalin Kothari, Stephanie Halene, Thomas Prebet, Mina L. Xu
Published 2021-09-01

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.

by Anne-Catherine Lhoumeau, Sébastien Martinez, Jean-Marie Boher, Geneviève Monges, Rémy Castellano, Armelle Goubard, Marie Doremus, Flora Poizat, Bernard Lelong, Cécile de Chaisemartin, Florence Bardin, Patrice Viens, Jean-Luc Raoul, Thomas Prebet, Michel Aurrand-Lions, Jean-Paul Borg, Anthony Gonçalves
Published 2015-01-01

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities

by Aude Le Roy, Aude Le Roy, Thomas Prébet, Rémy Castellano, Armelle Goubard, Florence Riccardi, Florence Riccardi, Cyril Fauriat, Cyril Fauriat, Samuel Granjeaud, Audrey Benyamine, Céline Castanier, Florence Orlanducci, Florence Orlanducci, Amira Ben Amara, Amira Ben Amara, Frédéric Pont, Jean-Jacques Fournié, Yves Collette, Jean-Louis Mege, Norbert Vey, Norbert Vey, Daniel Olive, Daniel Olive
Published 2018-05-01